You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oncolytic Immuno-gene therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Active, not recruiting
  • Prostate Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Health System
Feb 17, 2022

Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

Not yet recruiting
  • Refractory Metastatic Colorectal Cancer
  • +2 more
  • RP2
  • +3 more
  • Los Angeles, California
  • +5 more
Feb 24, 2023

Metastatic Pancreatic Cancer Trial in Detroit (Ad5-yCD/mutTKSR39rep-hIL12)

Completed
  • Metastatic Pancreatic Cancer
  • Ad5-yCD/mutTKSR39rep-hIL12
  • Detroit, Michigan
    Henry Ford Hospital
Feb 15, 2022

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Advanced Solid Tumor Trial in United Kingdom (RP3, Nivolumab)

Recruiting
  • Advanced Solid Tumor
  • RP3
  • Nivolumab
  • Houston, Texas
  • +6 more
Jan 30, 2023

Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • RP3
  • +3 more
  • (no location specified)
Feb 21, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

Metastatic NSCLC, Metastatic Triple-negative Breast Cancer Trial in Houston (biological, drug, radiation)

Active, not recruiting
Has Results
  • Metastatic Non-small Cell Lung Cancer
  • Metastatic Triple-negative Breast Cancer
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Cancer Center
Dec 28, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Heart Transplant, Immunosuppression, Allograft Trial (HeartCare)

Not yet recruiting
  • Heart Transplant
  • +2 more
  • HeartCare
  • (no location specified)
Jul 12, 2022

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
Has Results
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Hepatocellular Carcinoma Trial in Xi'an (Recombinant Human Adenovirus Type 5 injection, Sorafenib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Recombinant Human Adenovirus Type 5 injection
  • Sorafenib
  • Xi'an, Shaanxi, China
  • +3 more
Jan 25, 2022

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • OH2 injection
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jul 12, 2022

Tumors by Site Trial in Worldwide (Relatlimab, Nivolumab, BMS-986213)

Active, not recruiting
  • Neoplasms by Site
  • Relatlimab
  • +2 more
  • La Jolla, California
  • +52 more
Feb 10, 2022

Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

Recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Stockholm, Sweden
  • +1 more
Apr 4, 2022

Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor

Recruiting
  • Metastatic Malignant Peripheral Nerve Sheath Tumor
  • +2 more
  • Computed Tomography
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 6, 2022

Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

Completed
  • Follicular Lymphoma, Grade 1
  • +2 more
  • Alessandria, AL, Italy
  • +26 more
Jun 16, 2022

NSCLC Stage I Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP Adenovirus)

Withdrawn
  • Non-small Cell Lung Cancer Stage I
  • Ad5-yCD/mutTKSR39rep-ADP Adenovirus
  • Detroit, Michigan
    Henry Ford Health System
Aug 9, 2019

Hepatocellular Carcinoma Trial (Oncorine, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jan 30, 2023

Melanoma Trial in Beijing (OH2 injection, HX008 injection)

Recruiting
  • Melanoma
  • OH2 injection
  • HX008 injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jan 28, 2023

Pancreatic Cancer Trial in Houston (genetic, drug, biological)

Recruiting
  • Pancreatic Cancer
  • delolimogene mupadenorepvec
  • +3 more
  • Houston, Texas
  • +1 more
Sep 16, 2022

Dyad's Perspectives on Treatment Decision, Financial and Family

Recruiting
  • Breast Cancer
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jun 15, 2023

    Pancreatic Cancer Trial in Chongqing (OH2 injection)

    Recruiting
    • Pancreatic Cancer
    • OH2 injection
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 27, 2022